Free Trial

Addus HomeCare (ADUS) Competitors

$114.81
+3.08 (+2.76%)
(As of 05/31/2024 ET)

ADUS vs. OPCH, AMED, BTSG, AHCO, AVAH, EHAB, LHCG, CHE, VKTX, and ITCI

Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Option Care Health (OPCH), Amedisys (AMED), BrightSpring Health Services (BTSG), AdaptHealth (AHCO), Aveanna Healthcare (AVAH), Enhabit (EHAB), LHC Group (LHCG), Chemed (CHE), Viking Therapeutics (VKTX), and Intra-Cellular Therapies (ITCI). These companies are all part of the "medical" sector.

Addus HomeCare vs.

Addus HomeCare (NASDAQ:ADUS) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, community ranking, analyst recommendations and profitability.

Addus HomeCare presently has a consensus price target of $110.43, suggesting a potential downside of 3.82%. Option Care Health has a consensus price target of $40.00, suggesting a potential upside of 34.14%. Given Option Care Health's stronger consensus rating and higher possible upside, analysts clearly believe Option Care Health is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Addus HomeCare
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.75
Option Care Health
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Addus HomeCare received 254 more outperform votes than Option Care Health when rated by MarketBeat users. Likewise, 67.26% of users gave Addus HomeCare an outperform vote while only 58.97% of users gave Option Care Health an outperform vote.

CompanyUnderperformOutperform
Addus HomeCareOutperform Votes
300
67.26%
Underperform Votes
146
32.74%
Option Care HealthOutperform Votes
46
58.97%
Underperform Votes
32
41.03%

Option Care Health has higher revenue and earnings than Addus HomeCare. Option Care Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Addus HomeCare$1.06B1.78$62.52M$4.0328.49
Option Care Health$4.30B1.20$267.09M$1.5219.62

95.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 4.6% of Addus HomeCare shares are owned by company insiders. Comparatively, 0.6% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Addus HomeCare had 10 more articles in the media than Option Care Health. MarketBeat recorded 16 mentions for Addus HomeCare and 6 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.07 beat Addus HomeCare's score of 0.66 indicating that Option Care Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Addus HomeCare
2 Very Positive mention(s)
3 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Option Care Health
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Option Care Health has a net margin of 6.15% compared to Addus HomeCare's net margin of 6.04%. Option Care Health's return on equity of 18.92% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
Addus HomeCare6.04% 10.03% 6.97%
Option Care Health 6.15%18.92%8.37%

Addus HomeCare has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, Option Care Health has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.

Summary

Option Care Health beats Addus HomeCare on 10 of the 18 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADUS vs. The Competition

MetricAddus HomeCareHome health care services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.88B$2.82B$5.11B$7.96B
Dividend YieldN/A0.29%2.74%4.00%
P/E Ratio28.4911.14125.2115.57
Price / Sales1.781.172,429.7393.31
Price / Cash22.1414.1935.1031.51
Price / Book2.592.675.534.59
Net Income$62.52M-$57.02M$105.96M$213.90M
7 Day Performance2.87%-1.15%1.13%0.87%
1 Month Performance16.68%2.55%1.43%3.60%
1 Year Performance26.71%19.19%4.09%7.91%

Addus HomeCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPCH
Option Care Health
4.7686 of 5 stars
$29.43
-1.1%
$40.00
+35.9%
+8.2%$5.12B$4.30B19.367,802Short Interest ↑
Positive News
AMED
Amedisys
3.7015 of 5 stars
$95.68
+0.1%
$100.80
+5.4%
+20.0%$3.13B$2.24B-149.5019,000
BTSG
BrightSpring Health Services
2.79 of 5 stars
$11.39
+1.0%
$15.85
+39.2%
N/A$1.95B$8.83B0.0035,000Positive News
AHCO
AdaptHealth
3.5333 of 5 stars
$9.95
-1.6%
$12.42
+24.8%
-9.5%$1.33B$3.20B-1.8910,700Gap Down
AVAH
Aveanna Healthcare
0.2794 of 5 stars
$2.75
-1.1%
$1.80
-34.5%
+121.2%$529.05M$1.90B-4.5833,500Positive News
EHAB
Enhabit
3.0474 of 5 stars
$8.97
-1.3%
$10.13
+12.9%
-14.6%$449.85M$1.05B-5.4010,800Short Interest ↓
Positive News
LHCG
LHC Group
0 of 5 stars
$169.81
+0.5%
N/A+0.0%$5.27B$2.22B82.8330,000Analyst Forecast
High Trading Volume
CHE
Chemed
4.8457 of 5 stars
$539.90
-0.6%
$673.50
+24.7%
+4.0%$8.17B$2.26B29.0615,087
VKTX
Viking Therapeutics
4.4705 of 5 stars
$64.10
-1.9%
$112.38
+75.3%
+183.5%$7.07BN/A-68.9228Analyst Upgrade
ITCI
Intra-Cellular Therapies
4.4998 of 5 stars
$66.16
+0.8%
$90.17
+36.3%
+13.2%$6.98B$464.37M-57.03610Short Interest ↑

Related Companies and Tools

This page (NASDAQ:ADUS) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners